Hepatic iron loading in mice increases cholesterol biosynthesis

Iron and cholesterol are both essential metabolites in mammalian systems, and too much or too little of either can have serious clinical consequences. In addition, both have been associated with steatosis and its progression, contributing, inter alia, to an increase in hepatic oxidative stress. The...

Full description

Bibliographic Details
Main Authors: Graham, Ross, Chua, A., Carter, K., Delima, R., Johnstone, D., Herbison, C., Firth, M., O'Leary, R., Milward, E., Olynyk, J., Trinder, D.
Format: Journal Article
Published: John Wiley & Sons Inc. 2010
Online Access:http://hdl.handle.net/20.500.11937/11694
_version_ 1848747874373861376
author Graham, Ross
Chua, A.
Carter, K.
Delima, R.
Johnstone, D.
Herbison, C.
Firth, M.
O'Leary, R.
Milward, E.
Olynyk, J.
Trinder, D.
author_facet Graham, Ross
Chua, A.
Carter, K.
Delima, R.
Johnstone, D.
Herbison, C.
Firth, M.
O'Leary, R.
Milward, E.
Olynyk, J.
Trinder, D.
author_sort Graham, Ross
building Curtin Institutional Repository
collection Online Access
description Iron and cholesterol are both essential metabolites in mammalian systems, and too much or too little of either can have serious clinical consequences. In addition, both have been associated with steatosis and its progression, contributing, inter alia, to an increase in hepatic oxidative stress. The interaction between iron and cholesterol is unclear, with no consistent evidence emerging with respect to changes in plasma cholesterol on the basis of iron status. We sought to clarify the role of iron in lipid metabolism by studying the effects of iron status on hepatic cholesterol synthesis in mice with differing iron status. Transcripts of seven enzymes in the cholesterol biosynthesis pathway were significantly up-regulated with increasing hepatic iron (R2 between 0.602 and 0.164), including those of the rate-limiting enzyme, 3-hydroxy-3-methylglutarate-coenzyme A reductase (Hmgcr; R2 = 0.362, P < 0.002). Hepatic cholesterol content correlated positively with hepatic iron (R2 = 0.255, P < 0.007). There was no significant relationship between plasma cholesterol and either hepatic cholesterol or iron (R2 = 0.101 and 0.014, respectively). Hepatic iron did not correlate with a number of known regulators of cholesterol synthesis, including sterol-regulatory element binding factor 2 (Srebf2; R2 = 0.015), suggesting that the increases seen in the cholesterol biosynthesis pathway are independent of Srebf2. Transcripts of genes involved in bile acid synthesis, transport, or regulation did not increase with increasing hepatic iron. Conclusion: This study suggests that hepatic iron loading increases liver cholesterol synthesis and provides a new and potentially important additional mechanism by which iron could contribute to the development of fatty liver disease or lipotoxicity. (HEPATOLOGY 2010;)
first_indexed 2025-11-14T06:56:05Z
format Journal Article
id curtin-20.500.11937-11694
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:56:05Z
publishDate 2010
publisher John Wiley & Sons Inc.
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-116942023-02-22T06:24:19Z Hepatic iron loading in mice increases cholesterol biosynthesis Graham, Ross Chua, A. Carter, K. Delima, R. Johnstone, D. Herbison, C. Firth, M. O'Leary, R. Milward, E. Olynyk, J. Trinder, D. Iron and cholesterol are both essential metabolites in mammalian systems, and too much or too little of either can have serious clinical consequences. In addition, both have been associated with steatosis and its progression, contributing, inter alia, to an increase in hepatic oxidative stress. The interaction between iron and cholesterol is unclear, with no consistent evidence emerging with respect to changes in plasma cholesterol on the basis of iron status. We sought to clarify the role of iron in lipid metabolism by studying the effects of iron status on hepatic cholesterol synthesis in mice with differing iron status. Transcripts of seven enzymes in the cholesterol biosynthesis pathway were significantly up-regulated with increasing hepatic iron (R2 between 0.602 and 0.164), including those of the rate-limiting enzyme, 3-hydroxy-3-methylglutarate-coenzyme A reductase (Hmgcr; R2 = 0.362, P < 0.002). Hepatic cholesterol content correlated positively with hepatic iron (R2 = 0.255, P < 0.007). There was no significant relationship between plasma cholesterol and either hepatic cholesterol or iron (R2 = 0.101 and 0.014, respectively). Hepatic iron did not correlate with a number of known regulators of cholesterol synthesis, including sterol-regulatory element binding factor 2 (Srebf2; R2 = 0.015), suggesting that the increases seen in the cholesterol biosynthesis pathway are independent of Srebf2. Transcripts of genes involved in bile acid synthesis, transport, or regulation did not increase with increasing hepatic iron. Conclusion: This study suggests that hepatic iron loading increases liver cholesterol synthesis and provides a new and potentially important additional mechanism by which iron could contribute to the development of fatty liver disease or lipotoxicity. (HEPATOLOGY 2010;) 2010 Journal Article http://hdl.handle.net/20.500.11937/11694 10.1002/hep.23712 John Wiley & Sons Inc. unknown
spellingShingle Graham, Ross
Chua, A.
Carter, K.
Delima, R.
Johnstone, D.
Herbison, C.
Firth, M.
O'Leary, R.
Milward, E.
Olynyk, J.
Trinder, D.
Hepatic iron loading in mice increases cholesterol biosynthesis
title Hepatic iron loading in mice increases cholesterol biosynthesis
title_full Hepatic iron loading in mice increases cholesterol biosynthesis
title_fullStr Hepatic iron loading in mice increases cholesterol biosynthesis
title_full_unstemmed Hepatic iron loading in mice increases cholesterol biosynthesis
title_short Hepatic iron loading in mice increases cholesterol biosynthesis
title_sort hepatic iron loading in mice increases cholesterol biosynthesis
url http://hdl.handle.net/20.500.11937/11694